Posttranslational control of lipogenesis in the tumor microenvironment.

Cancer Lipid metabolism reprogramming Posttranslational modification Tumor microenvironment

Journal

Journal of hematology & oncology
ISSN: 1756-8722
Titre abrégé: J Hematol Oncol
Pays: England
ID NLM: 101468937

Informations de publication

Date de publication:
29 08 2022
Historique:
received: 13 04 2022
accepted: 11 08 2022
entrez: 29 8 2022
pubmed: 30 8 2022
medline: 1 9 2022
Statut: epublish

Résumé

Metabolic reprogramming of cancer cells within the tumor microenvironment typically occurs in response to increased nutritional, translation and proliferative demands. Altered lipid metabolism is a marker of tumor progression that is frequently observed in aggressive tumors with poor prognosis. Underlying these abnormal metabolic behaviors are posttranslational modifications (PTMs) of lipid metabolism-related enzymes and other factors that can impact their activity and/or subcellular localization. This review focuses on the roles of these PTMs and specifically on how they permit the re-wiring of cancer lipid metabolism, particularly within the context of the tumor microenvironment.

Identifiants

pubmed: 36038892
doi: 10.1186/s13045-022-01340-1
pii: 10.1186/s13045-022-01340-1
pmc: PMC9422141
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

120

Informations de copyright

© 2022. The Author(s).

Références

Cell Mol Life Sci. 2011 Jan;68(1):15-26
pubmed: 20730552
Nature. 2019 May;569(7754):73-78
pubmed: 30996346
Front Microbiol. 2016 Jun 17;7:962
pubmed: 27379086
Cancer Sci. 2019 Feb;110(2):481-488
pubmed: 30589983
Nat Rev Mol Cell Biol. 2020 Apr;21(4):225-245
pubmed: 31848472
Nat Rev Clin Oncol. 2019 Jul;16(7):425-441
pubmed: 30914826
Cancer Res. 2019 Sep 15;79(18):4557-4566
pubmed: 31350295
J Clin Invest. 2018 Dec 3;128(12):5647-5662
pubmed: 30352428
Hepatology. 2017 Jun;65(6):1936-1947
pubmed: 28027595
Oncogenesis. 2018 Aug 24;7(8):66
pubmed: 30140005
J Hematol Oncol. 2021 Nov 6;14(1):187
pubmed: 34742349
Mol Immunol. 2018 Feb;94:27-35
pubmed: 29248877
Adv Drug Deliv Rev. 2020;159:245-293
pubmed: 32711004
Signal Transduct Target Ther. 2020 Feb 29;5(1):11
pubmed: 32296023
J Lipid Res. 2018 May;59(5):749-763
pubmed: 29305383
Transl Gastroenterol Hepatol. 2018 Apr 23;3:20
pubmed: 29780898
Cancer Res. 2016 Dec 1;76(23):6924-6936
pubmed: 27758890
Nature. 2021 Mar;591(7849):306-311
pubmed: 33627871
Neoplasia. 2019 Jan;21(1):61-73
pubmed: 30504065
Antioxid Redox Signal. 2013 Aug 20;19(6):572-82
pubmed: 23088365
Biochem J. 2014 Aug 1;461(3):435-42
pubmed: 24840124
Immunotherapy. 2017 Mar;9(3):289-302
pubmed: 28231720
Mol Cancer. 2020 Feb 27;19(1):43
pubmed: 32106859
Bioessays. 2005 Apr;27(4):408-15
pubmed: 15770681
Sci China Life Sci. 2019 Sep;62(9):1117-1135
pubmed: 31144242
Nature. 2019 Feb;566(7744):403-406
pubmed: 30728499
Front Oncol. 2020 Oct 28;10:577420
pubmed: 33194695
Pharmacol Ther. 2020 Mar;207:107464
pubmed: 31863815
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Nat Rev Cancer. 2016 Nov;16(11):732-749
pubmed: 27658529
Biochem Pharmacol. 2011 Mar 1;81(5):649-60
pubmed: 21184748
Pharmacol Ther. 2018 Dec;192:88-99
pubmed: 29966598
J Lipid Res. 2018 Mar;59(3):507-514
pubmed: 29353240
Protein J. 2017 Feb;36(1):1-6
pubmed: 28108801
Trends Cell Biol. 2019 Sep;29(9):695-703
pubmed: 31160120
Expert Opin Ther Targets. 2017 Nov;21(11):1001-1016
pubmed: 28922023
J Biol Chem. 2008 Nov 14;283(46):31991-2002
pubmed: 18782761
Cancer Commun (Lond). 2018 May 21;38(1):27
pubmed: 29784041
Am J Physiol Endocrinol Metab. 2019 Dec 1;317(6):E1070-E1080
pubmed: 31593503
EMBO J. 2015 Jan 13;34(2):184-99
pubmed: 25425577
Am Soc Clin Oncol Educ Book. 2019 Jan;39:165-174
pubmed: 31099649
Trends Endocrinol Metab. 2015 Dec;26(12):676-687
pubmed: 26498855
Front Immunol. 2019 Feb 04;10:115
pubmed: 30778354
Int J Mol Sci. 2013 Apr 10;14(4):7742-56
pubmed: 23574936
Int J Biochem Cell Biol. 2021 Jan;130:105886
pubmed: 33227393
Essays Biochem. 2019 Apr 23;63(1):89-96
pubmed: 31015385
Redox Biol. 2019 Jul;25:101154
pubmed: 30853530
Cell Mol Life Sci. 2016 Apr;73(7):1439-55
pubmed: 26762302
Front Immunol. 2021 Feb 24;12:613492
pubmed: 33732237
Endocr Rev. 2018 Oct 1;39(5):760-802
pubmed: 30020428
Rinsho Byori. 2010 Feb;58(2):162-8
pubmed: 20229815
Mol Cancer Res. 2021 Apr;19(4):702-716
pubmed: 33372059
Int J Cancer. 2019 Nov 15;145(10):2611-2618
pubmed: 30989643
Biochemistry. 2020 Oct 20;59(41):3951-3964
pubmed: 32930581
Elife. 2013 Jul 23;2:e00953
pubmed: 23898401
Pharmacol Res. 2015 Dec;102:123-31
pubmed: 26438971
Mol Biol Rep. 2020 Apr;47(4):2635-2647
pubmed: 32125560
Curr Opin Biotechnol. 2021 Apr;68:240-250
pubmed: 33676144
Oncotarget. 2014 Oct 30;5(20):10017-33
pubmed: 25294820
Oncogene. 2020 Mar;39(11):2437-2449
pubmed: 31974474
J Biol Chem. 2018 Mar 16;293(11):4047-4055
pubmed: 29374057
Biochem Pharmacol. 2014 Nov 1;92(1):142-8
pubmed: 25199460
Immunity. 2019 Aug 20;51(2):381-397.e6
pubmed: 31350177
Cancer Res. 2020 Apr 1;80(7):1438-1450
pubmed: 32015091
Cancers (Basel). 2020 May 19;12(5):
pubmed: 32438640
Cell. 2019 Oct 31;179(4):829-845.e20
pubmed: 31675496
Semin Cancer Biol. 2022 Feb 10;:
pubmed: 35151845
Cell Metab. 2016 Apr 12;23(4):649-62
pubmed: 27076078
Transl Oncol. 2022 May;19:101386
pubmed: 35263700
Expert Rev Proteomics. 2017 Feb;14(2):157-170
pubmed: 28043171
Medicina (Kaunas). 2019 Dec 30;56(1):
pubmed: 31906017
Cell Metab. 2013 Aug 6;18(2):153-61
pubmed: 23791484
Adv Biol Regul. 2018 May;68:97-106
pubmed: 28942351
Nat Commun. 2020 Jan 23;11(1):438
pubmed: 31974378
Essays Biochem. 2020 Sep 23;64(3):579-589
pubmed: 32579188
J Exp Med. 2020 Aug 3;217(8):
pubmed: 32491160
Cancer Res. 2016 Mar 1;76(5):1260-72
pubmed: 26759235
Cell Death Dis. 2020 Apr 16;11(4):233
pubmed: 32300102
Medicina (B Aires). 2019;79(Spec 6/1):570-575
pubmed: 31864228
Princess Takamatsu Symp. 1986;17:233-40
pubmed: 2843496
Nat Immunol. 2013 May;14(5):489-99
pubmed: 23563690
Nanomicro Lett. 2021 Jan 4;13(1):31
pubmed: 34138236
Hepatology. 2021 Jan;73(1):160-174
pubmed: 32221968
Eur J Med Chem. 2018 Sep 5;157:1276-1291
pubmed: 30195238
Prog Lipid Res. 2022 Jan;85:101143
pubmed: 34856213
Nat Commun. 2020 Jan 23;11(1):437
pubmed: 31974367
Cancer Lett. 2017 Feb 1;386:1-11
pubmed: 27847303
Curr Top Microbiol Immunol. 2017;407:153-189
pubmed: 28550454
Sci China Life Sci. 2019 Nov;62(11):1420-1458
pubmed: 31686320
J Exp Clin Cancer Res. 2018 Jun 15;37(1):118
pubmed: 29907133
J Hematol Oncol. 2020 Aug 10;13(1):110
pubmed: 32778143
Hepatology. 2022 Apr 10;:
pubmed: 35398929
Cancer Cell. 2014 Jan 13;25(1):118-31
pubmed: 24434214
Cell Metab. 2019 Jun 4;29(6):1376-1389.e4
pubmed: 30930171
Dev Cell. 2020 Jan 27;52(2):196-209.e9
pubmed: 31866205
J Mol Cell Biol. 2017 Jun 1;9(3):195-208
pubmed: 28201649
Methods Mol Biol. 2021;2261:55-72
pubmed: 33420984
Nat Rev Endocrinol. 2016 Jan;12(1):43-60
pubmed: 26503676
Prog Lipid Res. 2020 Nov;80:101055
pubmed: 32791170
Cell Biochem Funct. 2020 Apr;38(3):283-289
pubmed: 31943290
Nat Metab. 2022 May;4(5):575-588
pubmed: 35534729
Yale J Biol Med. 2012 Mar;85(1):19-28
pubmed: 22461740
Nat Struct Mol Biol. 2007 Aug;14(8):704-9
pubmed: 17618296
Science. 2006 Jun 23;312(5781):1763-6
pubmed: 16794074
Br J Cancer. 2020 Jan;122(1):4-22
pubmed: 31819192
Cell Rep. 2021 Dec 28;37(13):110174
pubmed: 34965422
Nat Commun. 2020 Jan 13;11(1):240
pubmed: 31932588
Int J Mol Sci. 2019 Aug 24;20(17):
pubmed: 31450598
Immunology. 2021 Jul;163(3):293-309
pubmed: 33524161
Cells. 2021 Mar 30;10(4):
pubmed: 33808495
Gut. 2017 Dec;66(12):2149-2159
pubmed: 28258134
Curr Opin Cell Biol. 2017 Apr;45:31-37
pubmed: 28232179
Nat Commun. 2018 May 15;9(1):1916
pubmed: 29765047
Curr Protein Pept Sci. 2020;21(7):699-712
pubmed: 32379587
Cell Metab. 2020 Dec 1;32(6):967-980.e5
pubmed: 33264602
J Cell Mol Med. 2016 Jan;20(1):17-28
pubmed: 26493158
Adv Exp Med Biol. 2016;919:345-382
pubmed: 27975226
Nature. 2019 May;569(7755):270-274
pubmed: 31043744
Curr Opin Lipidol. 2012 Jun;23(3):226-234
pubmed: 22449814
EBioMedicine. 2019 Feb;40:406-421
pubmed: 30594553
BMB Rep. 2019 Feb;52(2):113-118
pubmed: 30638182
Cell Metab. 2017 Dec 5;26(6):842-855.e5
pubmed: 29056512
Immunol Cell Biol. 2018 Jan;96(1):21-33
pubmed: 29359507
Free Radic Biol Med. 2013 Dec;65:925-941
pubmed: 24002012
J Membr Biol. 2019 Oct;252(4-5):509-526
pubmed: 31485700
Gastroenterology. 2011 Mar;140(3):1071-83
pubmed: 21147110
Nature. 2020 Dec;588(7838):479-484
pubmed: 33177714
Cell Rep. 2018 Apr 17;23(3):741-755
pubmed: 29669281
Nat Commun. 2020 Jan 23;11(1):454
pubmed: 31974393
Mol Cancer. 2019 Mar 1;18(1):32
pubmed: 30823926
J Steroid Biochem Mol Biol. 2015 Jul;151:102-7
pubmed: 25218443
Adv Cancer Res. 2018;140:1-25
pubmed: 30060806
Front Immunol. 2019 Feb 08;10:168
pubmed: 30800125
JCI Insight. 2022 Feb 8;7(3):
pubmed: 34914638
Cell. 2019 Jun 27;178(1):160-175.e27
pubmed: 31155233
Biol Pharm Bull. 2011;34(10):1628-30
pubmed: 21963507
Mol Cell. 2017 Apr 6;66(1):154-162.e10
pubmed: 28344083
Nat Rev Endocrinol. 2017 Dec;13(12):710-730
pubmed: 28849786
Sci Transl Med. 2018 Apr 18;10(437):
pubmed: 29669855
Cancer Res. 2007 Sep 1;67(17):8180-7
pubmed: 17804731
Cancers (Basel). 2019 May 14;11(5):
pubmed: 31091767
Cell Metab. 2021 May 4;33(5):1001-1012.e5
pubmed: 33691090
FEBS J. 2012 Aug;279(15):2610-23
pubmed: 22621751
Science. 2012 Apr 27;336(6080):477-81
pubmed: 22539723
Annu Rev Med. 2016;67:103-17
pubmed: 26473416
Nat Rev Mol Cell Biol. 2007 Jul;8(7):530-41
pubmed: 17585314
J Biol Chem. 2017 Jun 2;292(22):9382-9393
pubmed: 28416613
Biochim Biophys Acta Mol Basis Dis. 2017 Dec;1863(12):3202-3211
pubmed: 28919365
Mol Cell. 2013 Aug 22;51(4):506-518
pubmed: 23932781
Biomed Res Int. 2018 Jul 4;2018:7801202
pubmed: 30069479
Cell Metab. 2020 Feb 4;31(2):422-437.e5
pubmed: 31883840
Cell Cycle. 2016 Oct 17;15(20):2753-65
pubmed: 27579997
Nature. 2016 Mar 31;531(7596):651-5
pubmed: 26982734
Diabetologia. 2014 Aug;57(8):1693-702
pubmed: 24913514
J Lipid Res. 2015 May;56(5):963-71
pubmed: 25713102
J Hepatol. 2013 Jun;58(6):1157-64
pubmed: 23369793
Mol Cell. 2011 Jul 22;43(2):203-16
pubmed: 21777810
Clin Cancer Res. 2015 Dec 15;21(24):5434-8
pubmed: 26519059
Mol Syst Biol. 2013 Dec 22;9:714
pubmed: 24366814
Int J Oncol. 2018 Apr;52(4):1081-1094
pubmed: 29484374
Biochem Biophys Res Commun. 2018 Oct 7;504(3):582-589
pubmed: 29438712
Curr Drug Targets. 2012 Dec;13(13):1654-8
pubmed: 23030498
Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3:264-72
pubmed: 25597633
Mol Med Rep. 2016 Dec;14(6):4931-4941
pubmed: 27779663
Front Oncol. 2020 Dec 08;10:596197
pubmed: 33425750
Cancer Lett. 2017 Feb 28;387:61-68
pubmed: 26845449
J Immunol. 2005 May 1;174(9):5390-7
pubmed: 15843537
Cancer Cell. 2015 Nov 9;28(5):569-581
pubmed: 26555173
Immunity. 2018 Jan 16;48(1):147-160.e7
pubmed: 29343435
Clin Proteomics. 2018 Sep 24;15:32
pubmed: 30258344
Mol Cell Endocrinol. 2019 Mar 1;483:97-101
pubmed: 30659843
Endocrinology. 2020 Feb 1;161(2):
pubmed: 31900483
Science. 2009 Jul 3;325(5936):100-4
pubmed: 19520913
Front Cell Dev Biol. 2017 Apr 26;5:43
pubmed: 28491867
Mol Cancer. 2017 Apr 11;16(1):76
pubmed: 28399876
Elife. 2018 Dec 13;7:
pubmed: 30543180
Mol Cancer. 2013 Nov 13;12:137
pubmed: 24225025
Cell Metab. 2005 Jun;1(6):379-91
pubmed: 16054087
Mol Cell. 2020 Jan 2;77(1):138-149.e5
pubmed: 31735643
Cell Rep. 2020 Oct 20;33(3):108278
pubmed: 33086073
Cell Metab. 2011 Apr 6;13(4):376-388
pubmed: 21459323
Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):2064-2074
pubmed: 28882874
Oncotarget. 2022 May 25;13:768-783
pubmed: 35634242
Adv Exp Med Biol. 2017;963:1-12
pubmed: 28197903
J Hepatol. 2015 Mar;62(3):720-33
pubmed: 25450203
Adv Exp Med Biol. 2020;1223:129-153
pubmed: 32030688
Commun Biol. 2019 Jul 31;2:281
pubmed: 31372520
J Biol Chem. 2013 Feb 8;288(6):3823-30
pubmed: 23269672
Cell Death Dis. 2020 Apr 23;11(4):267
pubmed: 32327627
Cell Metab. 2015 Apr 7;21(4):517-26
pubmed: 25863245
BMC Bioinformatics. 2019 May 1;20(Suppl 7):195
pubmed: 31074374
Int J Biochem Cell Biol. 2016 Sep;78:1-9
pubmed: 27343431
DNA Cell Biol. 2015 Nov;34(11):652-60
pubmed: 26309017
Int J Mol Sci. 2020 Dec 01;21(23):
pubmed: 33271935
Sci Adv. 2016 May 27;2(5):e1600200
pubmed: 27386546
Arch Biochem Biophys. 2019 Nov 15;676:108138
pubmed: 31606391
Cancer Gene Ther. 2021 Sep;28(9):984-999
pubmed: 33712707
Mol Cell. 2019 Oct 17;76(2):220-231
pubmed: 31586545
Sci Rep. 2015 Oct 01;5:14752
pubmed: 26424075

Auteurs

Yahui Zhu (Y)

Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430072, China.
Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, Wuhan, 430071, China.
School of Medicine, Chongqing University, Chongqing, 400030, China.

Xingrong Lin (X)

Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430072, China.
Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, Wuhan, 430071, China.

Xiaojun Zhou (X)

Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430072, China.
Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, Wuhan, 430071, China.

Edward V Prochownik (EV)

Division of Hematology/Oncology, Children's Hospital of Pittsburgh of UPMC, The Department of Microbiology and Molecular Genetics, The Pittsburgh Liver Research Center and The Hillman Cancer Center of UPMC, The University of Pittsburgh Medical Center, Pittsburgh, PA, 15224, USA.

Fubing Wang (F)

Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430072, China. wfb20042002@sina.com.

Youjun Li (Y)

Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430072, China. liy7@whu.edu.cn.
Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, Wuhan, 430071, China. liy7@whu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH